National Coalition for LGBTQ Health

Brief Type: News

CMS Administrator Nomination Stalls

April 19, 2021

The confirmation of President Joe Biden’s nomination to lead the Centers for Medicare & Medicaid Services (CMS) was delayed by top Senate Republican, Sen. John Cornyn (R-TX), over the recent Texas Medicaid waiver decision.

Gilead Sciences Proposes Change to Patient Assistance Program 

April 9, 2021

Gilead Sciences (Gilead) proposed a change to its Advancing Access Patient Assistance Program (PAP), which would require all PAP enrollees to receive their HIV medications (treatment and Pre-Exposure Prophylaxis (PrEP) through mail or courier delivery. This change poses significant challenges for 340B Covered Entities.

Democrats Reintroduce H.R.3., their Lower Drug Pricing Act

March 29, 2021

H.R.3 would allow the federal government to negotiate directly with drug companies as a way of lowering certain Medicare drug prices; and would give the Secretary of Health and Human Services (HHS) broad authority in determining the price of those particular drugs (250 of them).

A Freeze on the Trump-Era Drug “Rebate Rule” Stalls

March 18, 2021

The U.S. District Court for the District of Columbia has issued a court order delaying the Department of Health and Human Services’ (HHS) rule #0936-AA08 for almost two years. The rule, which changes payments to Pharmacy Benefit Managers in ways that disallow fluctuations based on the price of a drug, was slated to take effect January 2022. 

TennCare III Medicaid Program

January 16, 2021

CMS approved a waiver request from Tennessee that transitions TennCare II enrollees into the TennCare III Medicaid program. It’s been met with community opposition over fears that this program sends the message that “Modified Medicaid Block Grants” and capped spending for enrollees, are (back) on the menu.

National Coalition for LGBTQ Health

1630 Connecticut Ave. NW, Suite 500
Washington, DC 20009

202-232-6749 | [email protected]


© Copyright 2025 National Coalition for LGBTQ Health. All rights reserved. | Privacy Policy | Site Map